COMPANY
Greetings
About Us
Factory
Overseas Business
Recruitment
Location
PRODUCT
Product Search
Product News
R&D
Life Science Research Center
Research Fields
R&D Pipeline
INVESTMENT
Financial Information
IR
SERVICE
Customer Counseling
ECM
Declaration of self-compliance will
ISO Organization Chart and Greetings
Anti-Corruption Policy
Report of Corruption
COMPANY
Greetings
About Us
Factory
Overseas Business
Recruitment
Location
PRODUCT
Product Search
Product News
R&D
Life Science Research Center
Research Fields
R&D Pipeline
INVESTMENT
Financial Information
IR
SERVICE
Customer Counseling
ECM
Declaration of self-compliance will
ISO Organization Chart and Greetings
Anti-Corruption Policy
Report of Corruption
EN
KR
전체메뉴
INVESTMENT
COMPANY
PRODUCT
R&D
INVESTMENT
SERVICE
ECM
IR
Financial Information
IR
> INVESTMENT >
IR > Disclosure Information
INVESTMENT
IR
Jinyang Pharm pursues right management that
puts the interests of customers first.
Disclosure Information
Electronic Notice
.
03
2023.05
Interim Report on Business Performance(Fair Disclosure)
.
28
2023.04
Change of Market Division
.
07
2023.04
[Revised]Decision on Entering into Trust Contract for Acquisition of Treasury Stock(연장결정)
.
22
2023.03
Change of CEO
.
22
2023.03
Outcomes of Annual Meeting of Shareholders
.
14
2023.03
Submission of Audit Report
.
27
2023.02
Resolutions for Convocation of General Meeting of Shareholders
.
27
2023.02
[Revised]Decision on Cash Dividend and Dividend in Kind
.
06
2023.02
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)
.
06
2023.02
[Revised]Decision on Cash Dividend and Dividend in Kind
.
17
2023.01
Other Management Information(Voluntary Disclosure)(다파글리플로진 및 글리메피리드를 포함하는 약제학적 조성물 특허권 취득)
.
21
2022.12
[Revised]Decision on Entering into Trust Contract for Acquisition of Treasury Stock(연장결정)
.
19
2022.12
Decision on Cash Dividend and Dividend in Kind
.
16
2022.12
Decision to close the list of shareholders (reference date) for cash and in-kind dividends
.
18
2022.11
[Revised]Decision on Entering into Trust Contract for Acquisition of Treasury Stock(연장결정)
.
27
2022.10
Interim Report on Business Performance(Fair Disclosure)
.
24
2022.08
Decision on Acquisition of Treasury Stock
.
19
2022.08
Decision on Acquisition of Treasury Stock
.
12
2022.08
[Revised]Decision on Acquisition of Treasury Stock
.
12
2022.08
Decision on Acquisition of Treasury Stock
.
08
2022.04
[Revised]Decision on Entering into Trust Contract for Acquisition of Treasury Stock(연장결정)
.
23
2022.03
Outcomes of Annual Meeting of Shareholders
.
15
2022.03
Submission of Audit Report
.
28
2022.02
Resolutions for Convocation of General Meeting of Shareholders
.
28
2022.02
[Revised]Decision on Cash Dividend and Dividend in Kind
.
07
2022.02
[Revised]Decision on Cash Dividend and Dividend in Kind
.
07
2022.02
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)
.
21
2021.12
[Revised]Decision on Entering into Trust Contract for Acquisition of Treasury Stock(연장결정)
.
21
2021.12
Decision on Cash Dividend and Dividend in Kind
.
16
2021.12
Decision to close the list of shareholders (reference date) for cash and in-kind dividends
